Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro
Sandy Goyette,1,2 Yayun Liang,1,2 Benford Mafuvadze,1,2 Matthew T Cook,1,2 Moiz Munir,1,2 Salman M Hyder1,2 1Department of Biomedical Sciences, 2Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, USA Abstract: Clinical trials and studies have shown that combination estrogen...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-05-01
|
| Series: | Breast Cancer: Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/natural-and-synthetic-progestins-enrich-cancer-stem-cell-like-cells-in-peer-reviewed-article-BCTT |
| _version_ | 1818715177509453824 |
|---|---|
| author | Goyette S Liang Y Mafuvadze B Cook MT Munir M Hyder SM |
| author_facet | Goyette S Liang Y Mafuvadze B Cook MT Munir M Hyder SM |
| author_sort | Goyette S |
| collection | DOAJ |
| description | Sandy Goyette,1,2 Yayun Liang,1,2 Benford Mafuvadze,1,2 Matthew T Cook,1,2 Moiz Munir,1,2 Salman M Hyder1,2 1Department of Biomedical Sciences, 2Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, USA Abstract: Clinical trials and studies have shown that combination estrogen/progestin hormone replacement therapy, but not estrogen therapy alone or placebo, increases breast cancer risk in postmenopausal women. Using animal models, we have previously shown that both natural and synthetic progestins (including medroxyprogesterone acetate [MPA], a synthetic progestin used widely in the clinical setting) accelerate the development of breast tumors in vivo and increase their metastasis to lymph nodes. Based on these observations, we have hypothesized that progestin-induced breast cancer tumor growth and metastasis may be mediated by an enrichment of the cancer stem cell (CSC) pool. In this study, we used T47-D and BT-474 hormone-responsive human breast cancer cells to examine the effects of progestin on phenotypic and functional markers of CSCs in vitro. Both natural and synthetic progestins (10 nM) significantly increased protein expression of CD44, an important CSC marker in tumor cells. MPA increased the levels of both CD44 variants v3 and v6 associated with stem cell functions. This induction of CD44 was blocked by the antiprogestin RU-486, suggesting that this process is progesterone receptor (PR) dependent. CD44 induction was chiefly progestin dependent. Because RU-486 can bind other steroid receptors, we treated PR-negative T47-DCO-Y cells with MPA and found that MPA failed to induce CD44 protein expression, confirming that PR is essential for progestin-mediated CD44 induction in T47-D cells. Further, MPA treatment of T47-D cells significantly increased the activity of aldehyde dehydrogenase (ALDH), another CSC marker. Finally, two synthetic progestins, MPA and norethindrone, significantly increased the ability of T47-D cells to form mammospheres, suggesting that enrichment of the CD44high, ALDHbright subpopulation of cancer cells induced by MPA exposure is of functional significance. Based on our observations, we contend that exposure of breast cancer cells to synthetic progestins leads to an enrichment of the CSC pool, supporting the development of progestin-accelerated tumors in vivo. Keywords: breast cancer, progestins, medroxyprogesterone acetate, cancer stem cells, CD44, ALDH |
| first_indexed | 2024-12-17T18:59:13Z |
| format | Article |
| id | doaj.art-e7e1e7f8a244492e83730a56904c229b |
| institution | Directory Open Access Journal |
| issn | 1179-1314 |
| language | English |
| last_indexed | 2024-12-17T18:59:13Z |
| publishDate | 2017-05-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Breast Cancer: Targets and Therapy |
| spelling | doaj.art-e7e1e7f8a244492e83730a56904c229b2022-12-21T21:36:09ZengDove Medical PressBreast Cancer: Targets and Therapy1179-13142017-05-01Volume 934735732934Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitroGoyette SLiang YMafuvadze BCook MTMunir MHyder SMSandy Goyette,1,2 Yayun Liang,1,2 Benford Mafuvadze,1,2 Matthew T Cook,1,2 Moiz Munir,1,2 Salman M Hyder1,2 1Department of Biomedical Sciences, 2Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, USA Abstract: Clinical trials and studies have shown that combination estrogen/progestin hormone replacement therapy, but not estrogen therapy alone or placebo, increases breast cancer risk in postmenopausal women. Using animal models, we have previously shown that both natural and synthetic progestins (including medroxyprogesterone acetate [MPA], a synthetic progestin used widely in the clinical setting) accelerate the development of breast tumors in vivo and increase their metastasis to lymph nodes. Based on these observations, we have hypothesized that progestin-induced breast cancer tumor growth and metastasis may be mediated by an enrichment of the cancer stem cell (CSC) pool. In this study, we used T47-D and BT-474 hormone-responsive human breast cancer cells to examine the effects of progestin on phenotypic and functional markers of CSCs in vitro. Both natural and synthetic progestins (10 nM) significantly increased protein expression of CD44, an important CSC marker in tumor cells. MPA increased the levels of both CD44 variants v3 and v6 associated with stem cell functions. This induction of CD44 was blocked by the antiprogestin RU-486, suggesting that this process is progesterone receptor (PR) dependent. CD44 induction was chiefly progestin dependent. Because RU-486 can bind other steroid receptors, we treated PR-negative T47-DCO-Y cells with MPA and found that MPA failed to induce CD44 protein expression, confirming that PR is essential for progestin-mediated CD44 induction in T47-D cells. Further, MPA treatment of T47-D cells significantly increased the activity of aldehyde dehydrogenase (ALDH), another CSC marker. Finally, two synthetic progestins, MPA and norethindrone, significantly increased the ability of T47-D cells to form mammospheres, suggesting that enrichment of the CD44high, ALDHbright subpopulation of cancer cells induced by MPA exposure is of functional significance. Based on our observations, we contend that exposure of breast cancer cells to synthetic progestins leads to an enrichment of the CSC pool, supporting the development of progestin-accelerated tumors in vivo. Keywords: breast cancer, progestins, medroxyprogesterone acetate, cancer stem cells, CD44, ALDHhttps://www.dovepress.com/natural-and-synthetic-progestins-enrich-cancer-stem-cell-like-cells-in-peer-reviewed-article-BCTTbreast cancerprogestinsmedroxyprogesterone acetatecancer stem cellsCD44ALDH |
| spellingShingle | Goyette S Liang Y Mafuvadze B Cook MT Munir M Hyder SM Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro Breast Cancer: Targets and Therapy breast cancer progestins medroxyprogesterone acetate cancer stem cells CD44 ALDH |
| title | Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro |
| title_full | Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro |
| title_fullStr | Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro |
| title_full_unstemmed | Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro |
| title_short | Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro |
| title_sort | natural and synthetic progestins enrich cancer stem cell like cells in hormone responsive human breast cancer cell populations in vitro |
| topic | breast cancer progestins medroxyprogesterone acetate cancer stem cells CD44 ALDH |
| url | https://www.dovepress.com/natural-and-synthetic-progestins-enrich-cancer-stem-cell-like-cells-in-peer-reviewed-article-BCTT |
| work_keys_str_mv | AT goyettes naturalandsyntheticprogestinsenrichcancerstemcelllikecellsinhormoneresponsivehumanbreastcancercellpopulationsinvitro AT liangy naturalandsyntheticprogestinsenrichcancerstemcelllikecellsinhormoneresponsivehumanbreastcancercellpopulationsinvitro AT mafuvadzeb naturalandsyntheticprogestinsenrichcancerstemcelllikecellsinhormoneresponsivehumanbreastcancercellpopulationsinvitro AT cookmt naturalandsyntheticprogestinsenrichcancerstemcelllikecellsinhormoneresponsivehumanbreastcancercellpopulationsinvitro AT munirm naturalandsyntheticprogestinsenrichcancerstemcelllikecellsinhormoneresponsivehumanbreastcancercellpopulationsinvitro AT hydersm naturalandsyntheticprogestinsenrichcancerstemcelllikecellsinhormoneresponsivehumanbreastcancercellpopulationsinvitro |